OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Hematology is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
	676
The latest insights into rare blood disorders: Diagnosis and treatment strategies	390
Oh node: Extranodal nodular involvement of chronic lymphocytic leukemia in the colon	366
Not All Tryptase Elevations Are due to Acquired Clonal Mast Cell Disorders: When Tryptase Gene Copy Number Analysis Becomes Critical	224
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations	204
Autosomal Dominant Erythrocytosis Caused by Non‐Renal Erythropoietin ( EPO ) Due to EPO c	185
The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases	173
Primary Effusion Lymphoma Prognostic Score (PEL‐PS): A Validated International Prognostic Score in HIV‐Associated Primary Effusion Lymphoma	164
Teclistamab in patients with multiple myeloma and impaired renal function	145
Differential Prognosis and Transplant Strategies in CBF ‐ AML With	131
Reassessing the Duration of Induction Therapy for Newly Diagnosed, Transplant‐Eligible Myeloma Patients in the Context of Quadruple CD38 Monoclonal A	108
A First‐In‐Human Phase 1 Study of a Novel BCMA × CD3 Bispecific T Cell Engager	108
The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative	105
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers	94
R‐miniCHOP versus R‐CHOP in elderly patients with diffuse large B‐cell lymphoma: A propensity matched population‐based study	91
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia	90
TEG and ROTEM : Technology and Clinical Applications, 2026 Update	86
History of Thrombosis at High Altitude Associates With Increased Erythropoietin	84
Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia	82
The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms	82
Introduction to American Journal of Hematology Supplement: Improving Initial Care for Acute GVHD Patients	80
Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis	76
Aspirin use in essential thrombocythemia: Once‐daily or twice‐daily or not at all?	75
Are veterans at increased risk of myeloproliferative neoplasms?	74
Dendritic cell vaccines extend CAR T‐cell persistence and improve the efficacy of CD19 CAR T‐cell therapy in refractory or relapsed adult B‐ALL patients	73

Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia	72
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML	72
Overall Survival in Male Patients With Advanced Hematological Disease (Mostly Acute Leukemia) Is Influenced by CYP1B1 C432G Polymorphism and Donor Sex in Allogeneic Stem Cell Transpl	72
Clonal Hematopoiesis and Thrombosis	71
Peripheral Blood Erythrophagocytosis in Plasmodium falciparum Malaria	70
Polatuzumab Vedotin Combined With R ‐ ICE ( PolaR	69
Cytopenias revealing a case of carcinocythemia with bone marrow metastasis	65
Molecular and clinicopathologic characterization of pediatric histiocytoses	64
Therapeutic Errors Associated With Antithrombotic Medications Reported to United States Poison Centers	61
The impact of sex on platelet responses to aspirin in patients with peripheral artery disease	58
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data	56
Diagnosis and Management of Acute Chest Syndrome in Children With Sickle Cell Disease	54
Minutes Matter: An Audit of the Timeliness of Opioid Administration for Sickle Cell Disease Pain in the Emergency Department and Association With Disposition	52
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome	52
Intravenous Iron Associated Hypophosphatemia: Much More Than a Laboratory Curiosity	52
A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis	51
Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis and Splanchnic Vein Thrombosis: A Case Series	48
Table of Contents	48
Acute myeloid leukemia with mutated TP53: Is this newly proposed entity oversimplifying a complex group of neoplasms?	48
Triple A Plus ( AAA ⁺ ) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients	47
Harnessing the prognostic potential of PHF6 mutations in chronic myelomonocytic leukemia	47
Toward an improved understanding of hypomethylating agent and venetoclax therapies	46